Analyst Ratings for Antares Pharma (ATRS)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
4/14/2022 | Ladenburg Thalmann | Matthew Kaplan | Downgrade | Neutral (Buy) |
N/A (N/A) |
5.58 (5.59) |
0.18% | Details |
4/14/2022 | H.C. Wainwright | Oren Livnat | Downgrade | Neutral (Buy) |
5.60 (N/A) |
5.58 (5.59) |
0.18% | Details |